JJMP PHARMACEUTICALS LTD
C 34543
Registry information
- Registration number
- C 34543
- Legal form / type
- Limited Liability Company - Private Exempt
- Governing legislation
- Companies Act 1995
- Status
- Active
- Status effective date
- 2004-09-02
- Registration date
- 2004-09-02
- Registered office
- METROPOLIS, 52, TRIQ IL-GRECJA,
- Locality
- NAXXAR
- Postal code
- —
- Country / jurisdiction
- MALTA · MT
- Area of activity
- No Activity
Share capital & shareholders
- Total issued share capital
- €500.00
- Authorised capital
- 500 ordinary shares at EUR 2.329373 each
- Shareholders of record
- 2
- MR. Peter Mifsud
FLAT 2, THE ORCHIDSPALM STREET, THE GARDENS, SAN GILJAN
450 ordinary shares at EUR 2.329373 each · 20% paid up
- JJMP PHARMACEUTICALSC 34543
METROPOLIS, 52, TRIQ IL-GRECJA,, NAXXAR
50 ordinary shares at EUR 2.329373 each · 100% paid up
Officers & involved parties
Directors · 1
- MR. Peter Mifsud
FLAT 2, THE ORCHIDSPALM STREET, THE GARDENS, SAN GILJAN
Company secretaries · 1
- MR. Peter Mifsud
FLAT 2, THE ORCHIDSPALM STREET, THE GARDENS, SAN GILJAN
Representatives · 2
- MR. Peter MifsudJudicial Representative
FLAT 2, THE ORCHIDSPALM STREET, THE GARDENS, SAN GILJAN
- MR. Peter MifsudLegal Representative
FLAT 2, THE ORCHIDSPALM STREET, THE GARDENS, SAN GILJAN
Other involved parties · 3
- VCAAuditor
AB/26/84/46 · TA' XBIEX
- MR. Peter MifsudSubscribers
FLAT 2, THE ORCHIDSPALM STREET, THE GARDENS · SAN GILJAN
- JJMP PHARMACEUTICALSSubscribers
C 34543 · METROPOLIS, 52, TRIQ IL-GRECJA, · NAXXAR
Registry documents · 54 filed
Annual Return
C_34543/C_34543_D0052.pdf
FY 2026
filed 9 Sept 2026
Annual Accounts
C_34543/C_34543_D0051.pdf
FY 2025
filed 28 Jul 2026
Annual Return
C_34543/C_34543_D0050.pdf
FY 2025
filed 18 Sept 2025
Annual Return
C_34543/C_34543_D0049.pdf
FY 2024
filed 23 Jun 2025
Annual Accounts
C_34543/C_34543_D0048.pdf
FY 2024
filed 21 Jun 2025
Annual Accounts
C_34543/C_34543_D0047.pdf
FY 2023
filed 21 Jun 2025
Annual Return
C 34543/C_34543_D46_0.pdf
FY 2023
filed 19 Sept 2023
Accounts
C 34543/C_34543_D45_0.pdf
FY 2022
filed 16 Aug 2023